GS0051: Pharmaceutical preparations for the treatment of cardiovascular, autoimmune, neurological, cancer, hematological, inflammatory, respiratory, and transplantation related diseases and disorders
GS0421: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the field of pharmaceuticals for the treatment of cardiovascular, autoimmune, neurological, cancer, hematological, inflammatory, respiratory, and transplantation related diseases and disorders
N00000: The name shown in the mark does not identify a particular living individual.
Case File Event Statements
7/15/2019 - 4 years ago
15 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDType:MAB6
7/15/2019 - 4 years ago
14 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
12/11/2018 - 5 years ago
13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
10/16/2018 - 5 years ago
12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
10/16/2018 - 5 years ago
11 - PUBLISHED FOR OPPOSITIONType:PUBO
9/26/2018 - 5 years ago
10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
9/6/2018 - 5 years ago
9 - ASSIGNED TO LIEType:ALIE
8/23/2018 - 5 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
8/23/2018 - 5 years ago
7 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
8/23/2018 - 5 years ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
8/23/2018 - 5 years ago
5 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
8/23/2018 - 5 years ago
4 - EXAMINERS AMENDMENT -WRITTENType:CNEA
8/22/2018 - 5 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
5/9/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS